Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes

• Published in: Communications biology 2021-12, Vol.4 (1), p.1416-1416, Article 1416
• Main Authors: Sievers, Cem, Robbins, Yvette, Bai, Ke, Yang, Xinping, Clavijo, Paul E., Friedman, Jay, Sinkoe, Andrew, Norberg, Scott M., Hinrichs, Christian, Van Waes, Carter, Allen, Clint T.
• Format: Article
• Language: English
• Subjects: 38; 38/91; 45; 45/23; 631/250/2499; 631/326/596/2560; Adult; Antiviral agents; Biology; Biomedical and Life Sciences; Cell differentiation; Chronic infection; Female; Gene expression; Genome; Genomics; Head and neck carcinoma; Human papillomavirus; Human papillomavirus 11 - genetics; Human papillomavirus 6 - genetics; Humans; Life Sciences; Lung diseases; Male; Middle Aged; Mutagenesis; Papilloma; Papillomavirus Infections - virology; Respiratory Tract Infections - virology; Squamous cell carcinoma; Transcription; Transcriptome; Transcriptomics; Young Adult
• ISSN: 2399-3642; 2399-3642
• DOI: 10.1038/s42003-021-02942-0

Recurrent respiratory papillomatosis (RRP) is a debilitating neoplastic disorder of the upper aerodigestive tract caused by chronic infection with low-risk human papillomavirus types 6 or 11. Patients with severe RRP can require hundreds of lifetime surgeries to control their disease and pulmonary papillomatosis can be fatal. Here we report the comprehensive genomic and transcriptomic characterization of respiratory papillomas. We discovered and characterized distinct subtypes with transcriptional resemblance to either a basal or differentiated cell state that associate with disease aggressiveness and differ in key molecular, immune and APOBEC mutagenesis profiles. Through integrated comparison with high-risk HPV-associated head and neck squamous cell carcinoma, our analysis revealed divergent molecular and immune papilloma subtypes that form independent of underlying genomic alterations. Cumulatively our results support the development of dysregulated cellular proliferation and suppressed anti-viral immunity through distinct programs of squamous cell differentiation and associated expression of low-risk HPV genes. These analyses provide insight into the pathogenesis of respiratory papillomas and provide a foundation for the development of therapeutic strategies. Cem Sievers et al. performed genomic and transcriptomic analysis in human recurrent respiratory papillomatosis (RRP). They found that RRP harbors few genomic alterations, but that distinct transcriptional subtypes correlate with HPV gene expression and frequency of clinically-indicated interventions.